Ş. KÖSE Et Al. , "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment," WAO. MEXICO. Cancun. WAO Journal p , 2011
KÖSE, Ş. Et Al. 2011. Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment. WAO. MEXICO. Cancun. WAO Journal p .
KÖSE, Ş., yalçın, a., & parlak, g., (2011). Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment . WAO. MEXICO. Cancun. WAO Journal p
KÖSE, ŞÜKRAN, ad yalçın, And ge parlak. "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment," WAO. MEXICO. Cancun. WAO Journal p, 2011
KÖSE, ŞÜKRAN Et Al. "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment." WAO. MEXICO. Cancun. WAO Journal p , 2011
KÖSE, Ş. yalçın, a. And parlak, g. (2011) . "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment." WAO. MEXICO. Cancun. WAO Journal p .
@conferencepaper{conferencepaper, author={ŞÜKRAN KÖSE Et Al. }, title={Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment}, congress name={WAO. MEXICO. Cancun. WAO Journal p}, city={}, country={}, year={2011}}